CNTX
Context Therapeutics Inc - Under Sales Agreement, May Offer & Sell up to $75 Million in Common Stock
时间:2024-12-03 05:24:03 市场: 美股 综合
Context Therapeutics Inc - Enters Sales Agreement With Leerink Partners
时间:2024-12-03 05:24:03 市场: 美股 综合
Context Therapeutics Inc. Q3 Net Income USD -17.5 Million
时间:2024-11-07 05:06:13 市场: 美股 综合
Context Therapeutics Inc - Anticipates Ind Filing for Ba3362 in Mid-2026
时间:2024-09-23 19:30:15 市场: 综合 美股
Context Therapeutics Inc - Bioatla to Receive $15 Mln Upfront, up to $118.5 Mln in Milestones
时间:2024-09-23 19:30:15 市场: 美股 综合
Bioatla and Context Therapeutics Announce Exclusive Worldwide License Agreement to Develop and Commercialize Ba3362, a Nectin-4 X Cd3 T Cell Engaging Antibody
时间:2024-09-23 19:30:00 市场: 美股 综合